Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFE

Pfizer Inc

Dec 16 • 04:00PM ET

25.53

-0.90 -3.41 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Today, 6:50 AMAstellas and Pfizer today announced positive Phase 3 EV-304 topline results showing PADCEV plus Keytruda significantly improves event-free and overall survival in cisplatin-eligible muscle-invasive bladder cancer, with plans to discuss the data with regulators for potential filings.

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT DVY FDL

Scroll to Statements

Index	S&P 500	P/E	14.88	EPS (ttm)	1.72	Insider Own	0.09%	Shs Outstand	5.69B	Perf Week	0.79%
Market Cap	145.16B	Forward P/E	8.41	EPS next Y	3.04	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	1.88%
Enterprise Value	192.18B	PEG	-	EPS next Q	0.59	Inst Own	66.88%	Short Float	2.45%	Perf Quarter	6.15%
Income	9.80B	P/S	2.31	EPS this Y	0.38%	Inst Trans	-0.18%	Short Ratio	2.02	Perf Half Y	6.38%
Sales	62.78B	P/B	1.56	EPS next Y	-2.72%	ROA	4.58%	Short Interest	139.07M	Perf YTD	-3.77%
Book/sh	16.32	P/C	9.69	EPS next 5Y	-2.16%	ROE	10.59%	52W High	27.69 -7.80%	Perf Year	0.63%
Cash/sh	2.64	P/FCF	13.99	EPS past 3/5Y	-28.69% -13.27%	ROIC	6.52%	52W Low	20.92 22.07%	Perf 3Y	-50.64%
Dividend Est.	1.70 (6.67%)	EV/EBITDA	7.35	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	69.12%	Volatility	2.96% 2.40%	Perf 5Y	-39.00%
Dividend TTM	1.72 (6.74%)	EV/Sales	3.06	EPS Y/Y TTM	128.96%	Oper. Margin	30.99%	ATR (14)	0.65	Perf 10Y	-17.19%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	4.44%	Profit Margin	15.60%	RSI (14)	50.68	Recom	2.39
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.28	EPS Q/Q	-20.96%	SMA20	0.05%	Beta	0.43	Target Price	28.55
Payout	120.11%	Debt/Eq	0.66	Sales Q/Q	-5.92%	SMA50	1.68%	Rel Volume	1.64	Prev Close	26.43
Employees	81000	LT Debt/Eq	0.62	Earnings	Nov 04 BMO	SMA200	4.06%	Avg Volume	68.85M	Price	25.53
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	111,695,464	Change	-3.41%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47

Show Previous Ratings

Today 08:35AM	The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now (Motley Fool)
06:45AM	PADCEV Plus Keytruda Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility (PR Newswire)
Dec-16-25 05:50PM	Analyst Report: Pfizer Inc. (Morningstar Research)
05:45PM	Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
04:33PM	Stocks Settle Mixed on Soft US Economic News (Barchart)
04:24PM	Loading…
04:24PM	Stock Market Today: Dow Slides, Nasdaq Positive After Jobs Data; Nvidia Rises (Live Coverage) (Investor's Business Daily)
04:21PM	Monte Rosa Scores A Win In Prostate Cancer, And Rockets To A Four-Year High (Investor's Business Daily)
04:18PM	These Stocks Moved the Most Today: Tesla, Pfizer, Humana, Circle, CoreWeave, Broadcom, IonQ, Ford, Navan, and More (Barrons.com)
04:03PM	Tepid 2026 outlook dents Pfizer shares (AFP)
03:37PM	Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO (Yahoo Finance Video)
02:14PM	These Stocks Are Moving the Most Today: Tesla, Pfizer, Humana, Circle, CoreWeave, Broadcom, IonQ, Ford, Navan, and More (Barrons.com)
02:08PM	Stock Market Today: Dow Drops After Mixed Jobs Data; Cannabis Stocks Soar (Live Coverage) (Investor's Business Daily)
01:39PM	Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures (Pharmaceutical Technology)
01:08PM	Energy and healthcare stocks are dragging the market lower on Tuesday (MarketWatch)
01:04PM	Pfizer falls on disappointing guidance (CNBC TV)
12:07PM	Loading…
12:07PM	Pfizer CEO Defends Vaccines, Promises Growth by End of Decade (Barrons.com)
11:36AM	Why Pfizer (PFE) Stock Is Sliding Today (GuruFocus.com)
11:10AM	Pfizer Sees 2026 Profit Below Estimates as COVID Sales Decline (GuruFocus.com)
10:10AM	Why Pfizer's 2026 Guidance Miss Is 'Not A Major Surprise' (Investor's Business Daily)
09:40AM	Kraft Heinz taps new CEO, PayPal files for US bank charter (Yahoo Finance Video)
07:47AM	Here's why Pfizer is revising its revenue forecasts (MarketWatch)
07:25AM	Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales. (Barrons.com)
07:16AM	Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings (The Wall Street Journal)
07:03AM	Pfizer Adds to Its Big Bet on Weight Loss Drugs (MarketBeat)
06:45AM	Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance (Business Wire)
05:35AM	Where Will Eli Lilly Be in 10 Years? (Motley Fool)
Dec-15-25 09:32AM	BMY Gains 13.1% in Three Months: Buy, Sell or Hold the Stock? (Zacks)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
09:00AM	GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients (NewMediaWire)
Dec-14-25 03:47PM	Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? (Motley Fool)
07:13AM	Loading…
Dec-13-25 07:13AM	Forget Teladoc and Buy This Healthcare Stock Instead (Motley Fool)
Dec-12-25 12:00PM	Pfizer Declares First-Quarter 2026 Dividend (Business Wire)
11:52AM	Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. (Motley Fool)
11:17AM	Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win (Zacks)
10:35AM	The Best Turnaround Stock to Invest $1,000 in Right Now (Motley Fool)
Dec-11-25 02:03PM	Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.? (GuruFocus.com)
10:57AM	CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock? (Zacks)
10:09AM	Pfizer plans job cuts in Switzerland to reduce expenses (Pharmaceutical Technology)
07:49AM	Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth (Zacks)
07:32AM	Pfizer Inc. (PFE) Announces Results from Phase 3 BASIS Study (Insider Monkey)
03:45AM	Ex-Pfizer executive joins Elevances board as insurer pursues pharmacy experience (Healthcare Dive)
Dec-10-25 05:45PM	Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider (Zacks)
04:35PM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
11:47AM	This Invesco ETF Pays a 4.71% Yield With 50 Low-Volatility Dividend Stocks (3x the S&P 500) (24/7 Wall St.)
11:28AM	Pfizer Inc. (PFE) Announces Results from the Phase 3 BASIS Study Evaluating HYMPAVZI (Insider Monkey)
08:15AM	TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer (Business Wire)
07:43AM	PFE Buys Oral GLP-1 Drug From China Biotech to Boost Obesity Presence (Zacks)
07:31AM	JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now? (Zacks)
06:26AM	The Fed's Divided on Rates. Why Stock Markets Can Rise Through 2026 Anyway and 5 Other Things to Know Today. (Barrons.com)
04:30AM	China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer (South China Morning Post)
Dec-09-25 04:35PM	Down 50%, Should You Buy the Dip on Pfizer? (Motley Fool)
04:13PM	In The 'Uber Bull' Biotech Market, Is Structure The Next Metsera? (Investor's Business Daily)
01:40PM	Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal (Zacks)
12:30PM	Pfizer Expands Obesity Pipeline With Up to $2.1 Billion Deal for YaoPharma Pill (GuruFocus.com)
11:50AM	Pfizer Turns to China for Trial Weight Loss Drug. Congress Is Worried About Chinese Biotechs. (Barrons.com)
09:26AM	Pfizer gains another obesity asset with $2bn deal for YaoPharmas GLP-1RA (Pharmaceutical Technology)
06:30AM	Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma (Business Wire)
05:59AM	Pfizer dips into China for another try at an obesity pill (BioPharma Dive)
Dec-08-25 12:00PM	Drugmakers Are Ditching Middlemen to Sell Directly to Patients (The Wall Street Journal)
Dec-06-25 05:15PM	HYMPAVZI (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors (Business Wire)
09:52AM	Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue (24/7 Wall St.)
Dec-05-25 04:25PM	Do These 3 Healthcare Stocks Need a Checkup? (Motley Fool)
10:25AM	2 Headwinds Facing Pfizer Stock Going Into 2026 (Motley Fool)
10:24AM	3 Low-Volatility Stocks with Warning Signs (StockStory)
09:23AM	Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? (Zacks)
Dec-04-25 11:02PM	3 Reasons PFE is Risky and 1 Stock to Buy Instead (StockStory)
09:48PM	Pfizer Inc. (PFE): A Bull Case Theory (Insider Monkey)
11:30AM	Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue? (Zacks)
12:05AM	Jim Cramer on Pfizer: "I Would Hold on to It" (Insider Monkey)
Dec-02-25 12:28PM	LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website (Zacks)
12:11PM	17 dividend-stock bargains from a value manager with a stellar track record (MarketWatch)
10:24AM	Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure (Zacks)
09:40AM	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules (Zacks)
09:00AM	Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock (Zacks)
08:12AM	Vaccine stocks brace for shock waves at this weeks ACIP meeting (Investing.com)
08:02AM	How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint (Investor's Business Daily)
08:00AM	If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
07:44AM	2 Top Dividend Stocks to Buy Now and Hold For a Decade (Motley Fool)
Dec-01-25 04:41PM	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 (Investor's Business Daily)
03:05PM	FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks (Investopedia)
01:33PM	U.S., U.K. Strike Deal on Higher Drug Prices (The Wall Street Journal)
12:35PM	Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men (MarketWatch)
12:09PM	Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino (Yahoo Finance Video)
11:05AM	Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals (Barrons.com)
11:04AM	Will Korlym Continue to Drive Corcept's Top Line in 2026? (Zacks)
11:00AM	AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
10:27AM	Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals (The Wall Street Journal)
10:09AM	Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths (Investor's Business Daily)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance (Business Wire)
09:59AM	Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals (Barrons.com)
09:26AM	VKTX Stock Rises 34% in Three Months: Here's What You Should Know (Zacks)
08:12AM	Moderna Falls After FDA Vows to Impose New Vaccine Requirements (Bloomberg)
07:34AM	Shares of vaccine makers drop after FDA memo flags reports of child deaths (Investing.com)
06:00AM	Stock market holiday shopping: How to find quality value names (Yahoo Finance Video)
Nov-30-25 09:05PM	2 Undervalued, High-Quality Companies to Buy Now and Hold Forever (Motley Fool)
04:04PM	This 7% Yielder Could Be a Top AI Play (Motley Fool)
06:30AM	3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio (Motley Fool)
04:28AM	Will Michael Saylors Strategy Ever Join the S&P 500? (Cryptonews)
Nov-28-25 10:07AM	Biotechs Are On A Big Run, And Two Stocks Have Buy Points (Investor's Business Daily)
10:03AM	JNJ's Oncology Momentum Builds as It Chases $50B Goal by 2030 (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience